K E Langley

2.7k total citations
21 papers, 2.3k citations indexed

About

K E Langley is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, K E Langley has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Hematology and 10 papers in Immunology. Recurrent topics in K E Langley's work include Mast cells and histamine (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Peptidase Inhibition and Analysis (4 papers). K E Langley is often cited by papers focused on Mast cells and histamine (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Peptidase Inhibition and Analysis (4 papers). K E Langley collaborates with scholars based in United States, South Africa and France. K E Langley's co-authors include Yves A. DeClerck, K M Zsebo, Shirley M. Taylor, Thomas C. Boone, Hiroyuki Shimada, N Pérez, I K McNiece, Yves A. De Clerck, Irving Zabin and A.V. Fowler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

K E Langley

21 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K E Langley United States 19 854 748 747 732 574 21 2.3k
W A Galloway United Kingdom 11 668 0.8× 1.2k 1.7× 320 0.4× 759 1.0× 411 0.7× 15 2.2k
RA Ashmun United States 19 1.1k 1.3× 268 0.4× 487 0.7× 976 1.3× 378 0.7× 31 2.3k
Karin List United States 31 1.2k 1.4× 761 1.0× 362 0.5× 512 0.7× 589 1.0× 42 2.9k
Ian B. Pragnell United Kingdom 25 936 1.1× 169 0.2× 819 1.1× 785 1.1× 467 0.8× 62 2.2k
Pia Ragno Italy 26 761 0.9× 937 1.3× 312 0.4× 448 0.6× 476 0.8× 53 1.8k
Arko Gorter Netherlands 40 1.4k 1.6× 490 0.7× 2.2k 3.0× 1.5k 2.0× 260 0.5× 82 4.1k
Edward Pearlstein United States 26 789 0.9× 626 0.8× 282 0.4× 505 0.7× 514 0.9× 46 2.5k
Kimberly E. Foreman United States 29 1.8k 2.1× 738 1.0× 681 0.9× 1.7k 2.3× 188 0.3× 56 3.8k
Jiang-Hong Gong Canada 10 602 0.7× 627 0.8× 1.1k 1.4× 1.3k 1.8× 230 0.4× 11 2.4k
Tatsuo Senshu Japan 23 1.1k 1.3× 443 0.6× 820 1.1× 489 0.7× 139 0.2× 50 3.5k

Countries citing papers authored by K E Langley

Since Specialization
Citations

This map shows the geographic impact of K E Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K E Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K E Langley more than expected).

Fields of papers citing papers by K E Langley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K E Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K E Langley. The network helps show where K E Langley may publish in the future.

Co-authorship network of co-authors of K E Langley

This figure shows the co-authorship network connecting the top 25 collaborators of K E Langley. A scholar is included among the top collaborators of K E Langley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K E Langley. K E Langley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klimpel, Gary R., K E Langley, Jette Wypych, et al.. (1996). A role for stem cell factor (SCF): c-kit interaction(s) in the intestinal tract response to Salmonella typhimurium infection.. The Journal of Experimental Medicine. 184(1). 271–276. 39 indexed citations
2.
Turner, AM, et al.. (1995). Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood. 85(8). 2052–2058. 57 indexed citations
3.
Wypych, Jette, et al.. (1995). Soluble kit receptor in human serum. Blood. 85(1). 66–73. 59 indexed citations
4.
Montgomery, A M, Yves A. De Clerck, K E Langley, R. Reisfeld, & Barbara M. Mueller. (1993). Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.. PubMed. 53(3). 693–700. 94 indexed citations
5.
DeClerck, Yves A., et al.. (1993). Characterization of the functional domain of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochemical Journal. 289(1). 65–69. 57 indexed citations
6.
Langley, K E, et al.. (1993). Soluble stem cell factor in human serum. Blood. 81(3). 656–660. 18 indexed citations
7.
Knäuper, Vera, et al.. (1993). Fragmentation of human polymorphonuclear-leucocyte collagenase. Biochemical Journal. 291(3). 847–854. 98 indexed citations
8.
Langley, K E, et al.. (1993). Soluble stem cell factor in human serum. Blood. 81(3). 656–660. 120 indexed citations
9.
DeClerck, Yves A., N Pérez, Hiroyuki Shimada, et al.. (1992). Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.. PubMed. 52(3). 701–8. 375 indexed citations
10.
McNiece, I K, K E Langley, & K M Zsebo. (1991). The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7. The Journal of Immunology. 146(11). 3785–3790. 186 indexed citations
11.
Tsai, Mindy, H L Thompson, K E Langley, et al.. (1991). Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor.. Proceedings of the National Academy of Sciences. 88(14). 6382–6386. 358 indexed citations
12.
DeClerck, Yves A., et al.. (1991). Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. Journal of Biological Chemistry. 266(6). 3893–3899. 134 indexed citations
13.
Andrews, RG, GH Knitter, SH Bartelmez, et al.. (1991). Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood. 78(8). 1975–1980. 117 indexed citations
14.
Andrews, RG, GH Knitter, SH Bartelmez, et al.. (1991). Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood. 78(8). 1975–1980. 17 indexed citations
15.
Milich, David R., Janice Hughes, A. McLachlan, et al.. (1990). Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity.. The Journal of Immunology. 144(9). 3535–3543. 24 indexed citations
16.
Clerck, Yves A. De, et al.. (1989). Purification and Characterization of Two Related but Distinct Metalloproteinase Inhibitors Secreted by Bovine Aortic Endothelial Cells. Journal of Biological Chemistry. 264(29). 17445–17453. 178 indexed citations
17.
Zsebo, KM, Jette Wypych, H.S. Lu, et al.. (1988). Effects of hematopoietin-1 and interleukin 1 activities on early hematopoietic cells of the bone marrow. Blood. 71(4). 962–968. 55 indexed citations
18.
Zsebo, KM, Jette Wypych, H.S. Lu, et al.. (1988). Effects of hematopoietin-1 and interleukin 1 activities on early hematopoietic cells of the bone marrow. Blood. 71(4). 962–968. 4 indexed citations
19.
Langley, K E, A.V. Fowler, & Irving Zabin. (1975). Amino acid sequence of beta-galactosidase. IV. Sequence of an alpha-complementing cyanogen bromide peptide, residues 3 to 92.. Journal of Biological Chemistry. 250(7). 2587–2592. 52 indexed citations
20.
Langley, K E, Merna Villarejo, A.V. Fowler, Patrice J. Zamenhof, & Irving Zabin. (1975). Molecular basis of beta-galactosidase alpha-complementation.. Proceedings of the National Academy of Sciences. 72(4). 1254–1257. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026